Imax CEO Richard Gelfond Takes Temporary Medical Leave Due to Pneumonia

The reason for the executive's absence is to receive treatment for pneumonia, the company announced in a statement. Gelfond will not participate in public or private company events during his recovery, including the April CinemaCon convention in Las Vegas.

Imax has stated that it will provide updates as needed, but will respect Gelfond's privacy during his treatment. The company seeks transparency to avoid speculation about his absence, showing support for the CEO at this time.

The company has not specified the length of the medical leave, but has assured that the management team will take care of daily operations.

During Gelfond's absence, Imax's management team, in coordination with the chairman of the board of directors, Darren Throop, will continue with daily responsibilities. The management team, composed of Natasha Fernandes, Anne Globe, Rob Lister and Mark Welton, is in constant communication with the board of directors.

Darren Throop, chairman of the board of directors, stated that the management team is strong and experienced, and that they are focused on the growth and success of Imax. Throop sent his best wishes to Gelfond for a speedy recovery.

The transition will be smooth, ensuring the continuity of operations and the achievement of the company's goals, while Gelfond focuses on his health.

Imax achieved a record in the global box office of $1.2 billion in 2025, driven by hits like "F1", "Avatar: Fire and Ash" and "Sinners". This achievement demonstrates the company's strength and its ability to attract audiences.

The company aims to reach $1.4 billion in 2026, with the release of anticipated films such as Christopher Nolan's "The Odyssey", Denis Villeneuve's "Dune: Part Three" and "The Mandalorian and Grogu". This ambitious goal reflects Imax's confidence in its content strategy and its position in the film industry.

Imax's success is based on its projection technology and immersive experience, which attracts viewers and generates significant revenue at the global box office.

The absence of Richard Gelfond at CinemaCon, a crucial event for the film industry, is notable. CinemaCon is an important platform for Imax, where the latest developments are presented and relationships with studios and exhibitors are strengthened.

Although Gelfond will not be present, Imax's management team will participate in the event, ensuring the company's representation and the continuity of operations. Imax's participation in CinemaCon is vital to maintain its position in the industry and establish strategic alliances.

The temporary absence of Gelfond will not affect Imax's presence at CinemaCon, as the management team will continue with the scheduled activities and represent the company.

Imax's statement emphasizes transparency and respect for Richard Gelfond's privacy. The company seeks to keep its shareholders and the general public informed, while protecting the privacy of its CEO.

The support of the board of directors and the management team is essential to ensure the stability of the company during Gelfond's temporary absence. Unity and collaboration are key to overcoming this challenge.

Imax's response reflects its commitment to its employees, shareholders, and the public, demonstrating its ability to adapt and maintain its leadership in the film industry.